Amel Garnaoui-Meddeb
Tunis, Tunisia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Prospective cohort study of zoonotic cutaneous leishmaniasis in tunisia: Clinical and Immunological features and immune correlates of protection.
Journal: PLoS neglected tropical diseases
Published: March 06, 2022
Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
Journal: PLoS neglected tropical diseases
Published: July 09, 2019
Human cellular and humoral immune responses to Phlebotomus papatasi salivary gland antigens in endemic areas differing in prevalence of Leishmania major infection.
Journal: PLoS neglected tropical diseases
Published: April 17, 2017
Protein biomarkers discriminate Leishmania major-infected and non-infected individuals in areas endemic for cutaneous leishmaniasis.
Journal: BMC infectious diseases
Published: November 19, 2015
Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.
Journal: PloS one
Published: February 24, 2015
In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis.
Journal: PloS one
Published: October 23, 2013
Effects of Leishmania major clones showing different levels of virulence on infectivity, differentiation and maturation of human dendritic cells.
Journal: Clinical and experimental immunology
Published: August 07, 2012
DEAD-box proteins, like Leishmania eIF4A, modulate interleukin (IL)-12, IL-10 and tumour necrosis factor-alpha production by human monocytes.
Journal: Parasite immunology
Published: May 20, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026